Nifty Pharma Prediction for Monday, 20 July 2026: Index Falls Sharply, Down 1.40 Percent to 25,645.00

Nifty Pharma prediction for Monday 20 July 2026: index at 25,645.00, down 1.40 percent on Friday, the sole major sectoral decliner. Support 25,550. Resistance 25,980 and 26,150.

Nifty pharma prediction for monday: Nifty Pharma closed at 25,645.00 on Friday, down 363.05 points or 1.40 percent, the sole major sectoral decliner even as the broader market rallied to its strongest session in weeks, decisively reversing the sector’s earlier gains from Tuesday and Wednesday. This nifty pharma prediction for monday is built on Friday, 10 July 2026’s closing data, the last completed session before markets reopen on Monday, 13 July 2026.

Ankit Jaiswal, Senior Research Analyst at Univest, notes that the Nifty Pharma prediction for Monday reflects a genuine, decisive rotation out of defensives, since Friday’s sharp decline, coming precisely on the market’s strongest session in weeks, confirms money moved specifically away from pharma into cyclical, largecap-led names like IT and banking.

Click Here – Get Free Investment Predictions

Market Recap Behind the Nifty pharma prediction for monday

The index opened at 25,978.70, touched a high of 25,991.25 and a low of 25,549.25 before closing at 25,645.00, its weakest session in over a week. This decisively reverses the sector’s earlier 1.03 percent Tuesday and 0.37 percent Wednesday gains, confirming Friday’s rotation was a genuine shift rather than a brief pause.

Nifty pharma prediction for monday: Trend and Key Levels

Trend: Bearish Below 25,980

Ankit Jaiswal flags 25,550 as the key support, with 25,980 as the near-term resistance, matching Friday’s open. A close above 26,150 would suggest the sector is regaining favour, while a break under 25,400 would confirm the reversal has further room heading into the new trading week.

Global Cues for Nifty Pharma on Monday

Indian equities rallied sharply on Friday, led by IT and banking stocks and gains in Reliance Industries ahead of its Q1 FY27 results, even as crude oil extended its climb for a fifth straight session amid the unresolved Strait of Hormuz crisis. With markets shut over the weekend, this outlook for Monday, 20 July 2026, is built entirely on Friday’s closing data. Pharma remains largely insulated from these geopolitical and currency-driven cues, and Friday’s sharp decline looks like a clear rotation shift into cyclicals rather than any change in the sector’s own defensive fundamentals.

Key Triggers in the Nifty pharma prediction for monday

These triggers dominate the outlook heading into Monday, 13 July 2026:

• Continued rotation into cyclicals: If IT and banking keep leading, pharma could see further underperformance into the new week.
• US generic pricing developments: Any regulatory or pricing news from the US market remains an added sector-specific catalyst.
• HCL Technologies jumped 2.42 percent to Rs 1,203.90 on Friday, its third straight positive session, completing a full recovery from Tuesday’s post-results crash.

Talk to a SEBI Registered Investment Advisor Before Your Next Trade

Stocks to Watch in the Pharma Sector

Key pharma constituents worth tracking alongside the broader sector outlook.

Sun Pharma: Sun Pharma is a sector bellwether worth tracking for stock-level signals within the pharma space.

Nifty IT: Nifty IT jumped 1.75 percent on Friday, a primary destination for money rotating out of pharma.

Risks to the Nifty pharma prediction for monday

These factors can invalidate this outlook:

• Continued cyclical rotation: If IT and banking keep leading, pharma could see further relative underperformance.
• US regulatory setback: Any adverse FDA decision would compound the sector’s current weakness.
• Weekend risk-off reversal: Ironically, a market-wide sell-off could benefit pharma as investors rotate back into defensives.

Download the Univest iOS App or Univest Android App to track live Nifty Pharma levels and get daily research from SEBI registered analysts.

Conclusion

The Nifty Pharma prediction for Monday, 20 July 2026, is bearish below 25,980, after the sector decisively reversed its earlier weekly gains as money rotated sharply into IT and banking on Friday. Ankit Jaiswal flags 25,550 as the key support in the Nifty Pharma prediction for Monday, with a reversal of the current rotation the clearest path back to outperformance.

FAQs on the Nifty pharma prediction for monday

What is the Nifty Pharma prediction for Monday, 20 July 2026?

Ans. The Nifty Pharma prediction for Monday, 20 July 2026, is bearish below 25,980. The index closed at 25,645.00 on Friday, down 1.40 percent, the sole major sectoral decliner.

Which analyst gave the Nifty Pharma prediction for Monday?

Ans. Ankit Jaiswal, Senior Research Analyst at Univest, has shared the Nifty Pharma prediction for Monday, flagging 25,550 as the key support level.

Why did Nifty Pharma fall sharply while other sectors rallied on Friday?

Ans. Nifty Pharma fell 1.40 percent on Friday precisely as the broader market posted its strongest session in weeks, led by IT and banking instead, confirming a clear and decisive rotation away from defensives that the Nifty Pharma prediction for Monday treats as the key theme.

Did Nifty Pharma’s earlier gains this week get fully reversed?

Ans. Friday’s 1.40 percent decline more than offset the sector’s earlier 1.03 percent Tuesday and 0.37 percent Wednesday gains, confirming the Nifty Pharma prediction for Monday’s assessment that this was a genuine reversal rather than a brief pause.